Helen Tang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Helen Tang

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

Blood Advances|October 25, 2024

Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysisJoseph Pidala, Jongphil Kim, Denise Kalos, et al.

Clinical Nutrition (Edinburgh, Scotland)|December 16, 2023

Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trialPaul E Wischmeyer, Helen Tang, Yi Ren, et al.

Nature|January 28, 2021

Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibitionYael Cohen-Sharir, James M McFarland, Mai Abdusamad, et al.

Transplantation and Cellular Therapy|January 23, 2022

Home-Based Hematopoietic Cell Transplantation in the United StatesAnthony D Sung, Vinay K Giri, Helen Tang, et al.

Nature|August 10, 2018

Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben-David, Benjamin Siranosian, Gavin Ha, et al.

Transplantation and Cellular Therapy|May 20, 2022

Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 YearsMeagan V Lew, Yi Ren, Yen P Lowder, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

Blood Advances|October 25, 2024

Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysisJoseph Pidala, Jongphil Kim, Denise Kalos, et al.

Clinical Nutrition (Edinburgh, Scotland)|December 16, 2023

Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trialPaul E Wischmeyer, Helen Tang, Yi Ren, et al.

Nature|January 28, 2021

Aneuploidy renders cancer cells vulnerable to mitotic checkpoint inhibitionYael Cohen-Sharir, James M McFarland, Mai Abdusamad, et al.

Transplantation and Cellular Therapy|January 23, 2022

Home-Based Hematopoietic Cell Transplantation in the United StatesAnthony D Sung, Vinay K Giri, Helen Tang, et al.

Nature|August 10, 2018

Genetic and transcriptional evolution alters cancer cell line drug responseUri Ben-David, Benjamin Siranosian, Gavin Ha, et al.

Transplantation and Cellular Therapy|May 20, 2022

Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 YearsMeagan V Lew, Yi Ren, Yen P Lowder, et al.

Pageof 4